
ENDRA Life Sciences NDRA
€ 3.13
-1.84%
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Land |
|
IPO-Jahr |
2017 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
537 K |
Marktkapitalisierung |
$ 2 M |
EBITDA (LTM) |
$ -7.08 M |
P/E (LTM) |
-0.32 |
P/S (LTM) |
5.71 |
EPS (LTM) |
-11.77 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.95 | -1.17 % | $ 95.7 K | Nasdaq Capital Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Brainsway Ltd.
BWAY
|
$ 23.81 | 5.54 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 31.03 | 1.11 % | $ 344 M | Nasdaq Global Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.2 | 3.91 % | $ 1.53 M | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Castle Biosciences
CSTL
|
$ 32.42 | 0.59 % | $ 900 M | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 104.52 | -3.14 % | $ 4.12 B | Nasdaq Global Select Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 204.43 | 6.67 % | $ 22.7 B | NYSE,SPB | ||
|
Danaher Corporation
DHR
|
$ 219.39 | 1.25 % | $ 160 B | NYSE,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 20.51 | 1.58 % | $ 1.1 B | Nasdaq Global Market,SPB | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 11.04 | 5.54 % | $ 313 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 68.56 | -2.28 % | $ 26.5 B | Nasdaq Global Select Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.35 | 0.02 % | $ 19.2 B | Nasdaq Capital Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.82 | -1.62 % | $ 7.98 M | Nasdaq Global Select Market | ||
|
Fulgent Genetics
FLGT
|
$ 23.16 | 0.92 % | $ 700 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 105.16 | -0.17 % | $ 12.9 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Lantheus Holdings
LNTH
|
$ 66.52 | 2.01 % | $ 4.6 B | Nasdaq Global Select Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Charles River Laboratories International
CRL
|
$ 180.63 | -2.77 % | $ 9.28 B | NYSE,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 647.25 | 1.17 % | $ 53.4 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 118.45 | 1.02 % | $ 18.8 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 183.03 | -5.04 % | $ 33.2 B | NYSE,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 33.03 | 11.44 % | $ 20 B | NYSE | ||
|
Quidel Corporation
QDEL
|
$ 29.3 | 0.12 % | $ 1.23 B | Nasdaq Global Select Market,SPB | ||
|
Biodesix
BDSX
|
$ 10.52 | 5.94 % | $ 1.36 B | Nasdaq Global Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 397.63 | 1.19 % | $ 28.8 B | NYSE,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 282.89 | 3.24 % | $ 23.7 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 145.76 | -5.7 % | $ 12 B | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 11.52 | 1.5 % | $ 1.46 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.29 | 5.53 % | $ 5.26 M | Nasdaq Capital Market | ||
|
Bioventus
BVS
|
$ 8.08 | -5.16 % | $ 506 M | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 449.33 | -15.28 % | $ 13.9 B | Nasdaq Global Select Market,SPB |